• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国食管癌统计数据,2011 年:基于 177 个癌症登记处的估计。

Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries.

机构信息

National Office for Cancer Prevention and Control Cancer Hospital, Chinese Academy of Medical Sciences Beijing China.

出版信息

Thorac Cancer. 2016 Mar;7(2):232-7. doi: 10.1111/1759-7714.12322. Epub 2015 Dec 7.

DOI:10.1111/1759-7714.12322
PMID:27042227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4773307/
Abstract

BACKGROUND

Esophageal cancer has been a common cancer in China for many years. Using the most recent data collected from the National Central Cancer Registry, we present estimates of the esophageal cancer burden in China in 2011.

METHODS

Age-specific incidence and mortality rates by gender and area for 18 age groups were calculated based on data from 177 qualified population-based cancer registries. The number of new cases of esophageal cancer and cancer deaths were computed by multiplying these rates by the 2011 population. Crude incidence and mortality rates of esophageal cancer were estimated.

RESULTS

The estimated number of new esophageal cancer cases and deaths were 291 238 and 218 957, respectively. The crude incidence and mortality rates for esophageal cancer were 21.62/100 000 and 16.25/100 000, respectively. The age-standardized incidence and mortality rates by world population were 15.83/100 000 and 11.62/100 000, respectively. Both the incidence and mortality rates of esophageal cancer were higher in rural areas than in urban areas, and in men than in women. The age-specific esophageal cancer incidence and mortality rates increased with age. In China, squamous cell cancer was the most common pathological type of the disease.

CONCLUSION

Esophageal cancer remains a major public health issue in China. Primary and secondary prevention are essential for disease control.

摘要

背景

食管癌在中国已经是一种多年来常见的癌症。利用国家癌症中心最新收集的癌症登记数据,我们对 2011 年中国食管癌的发病负担进行了评估。

方法

根据来自 177 个合格的基于人群的癌症登记处的数据,计算了 18 个年龄组按性别和地区划分的特定年龄组的发病率和死亡率。通过将这些比率乘以 2011 年的人口数,计算出食管癌新发病例和癌症死亡人数。估计食管癌的粗发病率和死亡率。

结果

估计食管癌新发病例和死亡人数分别为 291238 例和 218957 例。食管癌的粗发病率和死亡率分别为 21.62/10 万和 16.25/10 万。按世界人口计算的年龄标准化发病率和死亡率分别为 15.83/10 万和 11.62/10 万。食管癌的发病率和死亡率均高于农村地区,男性高于女性。食管癌的年龄特异性发病率和死亡率随年龄增长而增加。在中国,鳞状细胞癌是最常见的疾病病理类型。

结论

食管癌仍然是中国的一个主要公共卫生问题。初级和二级预防对于疾病控制至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/4773307/afa4896c9510/TCA-7-232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/4773307/c7f76d334006/TCA-7-232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/4773307/afa4896c9510/TCA-7-232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/4773307/c7f76d334006/TCA-7-232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d688/4773307/afa4896c9510/TCA-7-232-g002.jpg

相似文献

1
Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries.中国食管癌统计数据,2011 年:基于 177 个癌症登记处的估计。
Thorac Cancer. 2016 Mar;7(2):232-7. doi: 10.1111/1759-7714.12322. Epub 2015 Dec 7.
2
Esophageal cancer incidence and mortality in China, 2010.中国 2010 年食管癌发病与死亡分析
Thorac Cancer. 2014 Jul;5(4):343-8. doi: 10.1111/1759-7714.12100. Epub 2014 Jul 3.
3
The incidence and mortality of major cancers in China, 2012.2012年中国主要癌症的发病率和死亡率。
Chin J Cancer. 2016 Aug 2;35(1):73. doi: 10.1186/s40880-016-0137-8.
4
National cancer incidence and mortality in China, 2012.2012年中国国家癌症发病率与死亡率
Chin J Cancer Res. 2016 Feb;28(1):1-11. doi: 10.3978/j.issn.1000-9604.2016.02.08.
5
[Incidence and mortality of cervical cancer in China, 2014].[2014年中国宫颈癌的发病率与死亡率]
Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):241-246. doi: 10.3760/cma.j.issn.0253-3766.2018.04.001.
6
[Analysis and prediction of esophageal cancer incidence trend in China].[中国食管癌发病趋势的分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):593-7.
7
Female breast cancer incidence and mortality in China, 2013.中国 2013 年女性乳腺癌发病与死亡。
Thorac Cancer. 2017 May;8(3):214-218. doi: 10.1111/1759-7714.12426. Epub 2017 Mar 13.
8
Esophageal cancer incidence and mortality in China, 2009.中国 2009 年食管癌发病与死亡分析
J Thorac Dis. 2013 Feb;5(1):19-26. doi: 10.3978/j.issn.2072-1439.2013.01.04.
9
[Mortality and survival analysis of esophageal cancer in China].[中国食管癌的死亡率与生存分析]
Zhonghua Zhong Liu Za Zhi. 2016 Sep 23;38(9):709-15. doi: 10.3760/cma.j.issn.0253-3766.2016.09.014.
10
Incidence and mortality of breast cancer in China, 2008.2008年中国乳腺癌的发病率和死亡率
Thorac Cancer. 2013 Feb;4(1):59-65. doi: 10.1111/j.1759-7714.2012.00165.x.

引用本文的文献

1
Inhibition of esophageal squamous cell carcinoma progression by MIR210HG and activation of the P53 signaling pathway to promote apoptosis and autophagy.MIR210HG抑制食管鳞状细胞癌进展并激活P53信号通路以促进细胞凋亡和自噬。
Eur J Med Res. 2025 Apr 11;30(1):269. doi: 10.1186/s40001-025-02512-8.
2
Circ_DLG1 facilitates cell proliferation and metastasis of esophageal squamous cell carcinoma via upregulating MAP3K9.环状DLG1通过上调MAP3K9促进食管鳞状细胞癌的细胞增殖和转移。
Esophagus. 2025 Apr;22(2):250-263. doi: 10.1007/s10388-025-01115-w. Epub 2025 Mar 5.
3
Iodine Staining With Distance Countdown Improving the Safety for Reduction of Adverse Events: A Randomized Controlled Trial.

本文引用的文献

1
Annual report on status of cancer in China, 2011.《2011年中国癌症现状年度报告》
Chin J Cancer Res. 2015 Feb;27(1):2-12. doi: 10.3978/j.issn.1000-9604.2015.01.06.
2
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
3
Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China.中国河南地区食管腺癌及其与巴雷特食管的罕见关联
碘染色结合距离倒计时可提高减少不良事件的安全性:一项随机对照试验。
Clin Transl Gastroenterol. 2025 Mar 1;16(3):e00822. doi: 10.14309/ctg.0000000000000822.
4
Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers.对14个手术代表性中心的食管癌患者的疾病特征和治疗模式进行回顾性分析。
Cancer Biol Med. 2025 Jan 17;21(12):1171-84. doi: 10.20892/j.issn.2095-3941.2024.0336.
5
Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy.伴有EP300突变的食管鳞状细胞癌表现出与新辅助放化疗相关的独特基因特征。
World J Surg Oncol. 2025 Jan 2;23(1):1. doi: 10.1186/s12957-024-03642-9.
6
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.帕博利珠单抗联合化疗一线治疗中国晚期/复发或转移性食管鳞状细胞癌患者的有效性和安全性:一项真实世界多中心研究
Ther Adv Med Oncol. 2024 Nov 19;16:17588359241297092. doi: 10.1177/17588359241297092. eCollection 2024.
7
Dysbiosis of the Upper Gastrointestinal Tract in Head-and-Neck Cancer Survivors: A Pilot Study Using the Capsule Sponge Device.头颈癌幸存者上消化道微生物失调:一项使用胶囊海绵装置的初步研究
Cancers (Basel). 2024 Oct 18;16(20):3528. doi: 10.3390/cancers16203528.
8
Establishment and validation of the prognostic risk model based on the anoikis-related genes in esophageal squamous cell carcinoma.基于失巢凋亡相关基因的食管鳞癌预后风险模型的建立与验证。
Ann Med. 2024 Dec;56(1):2418338. doi: 10.1080/07853890.2024.2418338. Epub 2024 Oct 23.
9
Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis.新辅助放化疗与新辅助免疫化疗治疗局部晚期食管鳞癌患者的病理反应和生存结局比较:倾向评分匹配分析。
BMC Cancer. 2024 Oct 5;24(1):1228. doi: 10.1186/s12885-024-12946-8.
10
Porphyromonas gingivalis lipopolysaccharide regulates cell proliferation, apoptosis, autophagy in esophageal squamous cell carcinoma via TLR4/MYD88/JNK pathway.牙龈卟啉单胞菌脂多糖通过TLR4/MYD88/JNK途径调节食管鳞状细胞癌的细胞增殖、凋亡和自噬。
J Clin Biochem Nutr. 2024 May;74(3):213-220. doi: 10.3164/jcbn.22-138. Epub 2023 Nov 23.
PLoS One. 2014 Oct 15;9(10):e110348. doi: 10.1371/journal.pone.0110348. eCollection 2014.
4
Cancer survival in China, 2003-2005: a population-based study.2003 - 2005年中国癌症生存率:一项基于人群的研究。
Int J Cancer. 2015 Apr 15;136(8):1921-30. doi: 10.1002/ijc.29227. Epub 2014 Oct 3.
5
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
6
Esophageal cancer incidence and mortality in China, 2009.中国 2009 年食管癌发病与死亡分析
J Thorac Dis. 2013 Feb;5(1):19-26. doi: 10.3978/j.issn.2072-1439.2013.01.04.
7
Esophageal cancer incidence rates by histological type and overall: Puerto Rico versus the United States Surveillance, Epidemiology, and End Results population, 1992-2005.1992-2005 年波多黎各与美国监测、流行病学和最终结果人群按组织学类型和总体划分的食管癌发病率。
Cancer Epidemiol. 2013 Feb;37(1):5-10. doi: 10.1016/j.canep.2012.09.002. Epub 2012 Oct 11.
8
[Analysis and prediction of esophageal cancer incidence trend in China].[中国食管癌发病趋势的分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):593-7.
9
Trends in esophageal cancer incidence by histology, United States, 1998-2003.1998 - 2003年美国按组织学分类的食管癌发病率趋势
Int J Cancer. 2008 Sep 15;123(6):1422-8. doi: 10.1002/ijc.23691.
10
A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes.一项关于烟草、酒精与食管癌和胃癌亚型风险的前瞻性研究。
Am J Epidemiol. 2007 Jun 15;165(12):1424-33. doi: 10.1093/aje/kwm051. Epub 2007 Apr 9.